z-logo
open-access-imgOpen Access
Histone Methyltransferase G9a Is Required for Cardiomyocyte Homeostasis and Hypertrophy
Author(s) -
Roberto Papait,
Simone Serio,
Christina Pagiatakis,
Francesca Rusconi,
Pierluigi Carullo,
Marta Mazzola,
Nicolò Salvarani,
Michele Miragoli,
Gianluigi Condorelli
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.117.028561
Subject(s) - epigenetics , biology , epigenome , mef2c , histone methyltransferase , histone , chromatin , histone h3 , chromatin immunoprecipitation , epigenomics , microbiology and biotechnology , methyltransferase , transcription factor , gene expression , genetics , gene , promoter , dna methylation , methylation
Correct gene expression programming of the cardiomyocyte underlies the normal functioning of the heart. Alterations to this can lead to the loss of cardiac homeostasis, triggering heart dysfunction. Although the role of some histone methyltransferases in establishing the transcriptional program of postnatal cardiomyocytes during heart development has been shown, the function of this class of epigenetic enzymes is largely unexplored in the adult heart. In this study, we investigated the role of G9a/Ehmt2, a histone methyltransferase that defines a repressive epigenetic signature, in defining the transcriptional program for cardiomyocyte homeostasis and cardiac hypertrophy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom